Results 231 to 240 of about 12,336,620 (246)

A Scoring System for the Classification of CD5- B CLL versus CD5+ B CLL and B PLL

Leukemia and Lymphoma, 1995
H Merle-Beral, F Valensi, Georges Flandrin   +2 more
exaly  

Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases

British Journal of Haematology, 1997
A Criel, P Meeus, M Boogaerts
exaly  

Altered expression of metabolic pathways in CLL detected by unlabelled quantitative mass spectrometry analysis

British Journal of Haematology, 2019
Lauren Thurgood, Tim Chataway, Karen Lower   +2 more
exaly  

p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes

Leukemia Research, 2011
James Johnston, Denis Soulieres, Raquel Aloyz   +2 more
exaly  

The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology?

Blood Reviews, 2015
Xiaojun Huang, Jian-Yong Li
exaly  

Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting

Seminars in Cancer Biology, 2010
Jan A Bürger
exaly  

CML as a Second Cancer after CLL

Ca-A Cancer Journal for Clinicians, 1981
exaly  

Molecular and cellular mechanisms of CLL: novel therapeutic approaches

Nature Reviews Clinical Oncology, 2009
Tanja Nicole Hartmann, Lisa Pleyer, Richard Greil   +2 more
exaly  

Editor's Reply: H. G. Wells on Cancer

Ca-A Cancer Journal for Clinicians, 1981
exaly  

Author's Reply: CML as a Second Cancer after CLL

Ca-A Cancer Journal for Clinicians, 1981
exaly